These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2642250)

  • 1. The effects of D-penicillamine on the renal and liver functions in neonates and the in vitro influence on granulocytes.
    Lakatos L; Szabó I; Csáthy L
    Acta Paediatr Scand Suppl; 1989; 360():135-9. PubMed ID: 2642250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [D-penicillamine does not affect the liver and kidney function in newborn infants nor the in vitro function of phagocytes].
    Csáthy L; Szabó I; Pataki M; Lakatos L; Maródi L
    Orv Hetil; 1991 Nov; 132(44):2421-3. PubMed ID: 1945383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of D-penicillamine on metabolic and functional activities of neutrophil granulocytes.
    Szabó I; Maródi L; Karmazsin L; Lakatos L
    Acta Paediatr Hung; 1990; 30(3-4):449-59. PubMed ID: 1964571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of D-penicillamine to prevent retinopathy of prematurity.
    Lakatos L; Hatvani I; Oroszlán G; Balla G; Karmazsin L; Alaka O; Kincses E; Szabó I; Lakatos Z
    Acta Paediatr Hung; 1986; 27(1):47-56. PubMed ID: 3524608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Penicillamine administration and the incidence of retinopathy of prematurity.
    Christensen RD; Alder SC; Richards SC; Lambert DK; Schmutz N; Wiedmeier SE; Burnett J; Baer VL; Horn JT; Richards M; Barraza J
    J Perinatol; 2007 Feb; 27(2):103-11. PubMed ID: 17262043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent administration of D-penicillamine and zinc has no advantages over the use of either single agent on copper excretion in the rat.
    Domingo JL; Gómez M; Jones MM
    Toxicology; 1998 Apr; 126(3):195-201. PubMed ID: 9674967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Penicillamine D therapy of hemolytic disease of newborn and neonatal hyperbilirubinemia].
    Lakatos L; Kövér B; Dvoracsek E; Vekerdy Z
    Orv Hetil; 1975 Aug; 116(32):1863-8. PubMed ID: 1170536
    [No Abstract]   [Full Text] [Related]  

  • 8. Spatial investigation of the elemental distribution in Wilson's disease liver after d-penicillamine treatment by LA-ICP-MS.
    Hachmöller O; Zibert A; Zischka H; Sperling M; Groba SR; Grünewald I; Wardelmann E; Schmidt HH; Karst U
    J Trace Elem Med Biol; 2017 Dec; 44():26-31. PubMed ID: 28965585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Penicillamine (experimental study)].
    Veĭs RA; Storzhev IA; Mogilevchik LE; Sazykin IuO; Voronina RM
    Antibiotiki; 1969 Sep; 14(9):837-40. PubMed ID: 5361828
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of D-penicillamine on urinary copper excretion in high-copper supplemented sheep.
    Humann-Ziehank E; Bickhardt K
    J Vet Med A Physiol Pathol Clin Med; 2001 Nov; 48(9):537-44. PubMed ID: 11765810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates.
    Christensen RD; Alder SC; Richards SC; Horn JT; Lambert DK; Baer VL
    J Perinatol; 2006 Feb; 26(2):120-4. PubMed ID: 16407960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Letter: The use of penicillamine D in the therapy of hyperbilirubinemia in newborn infants].
    Dolinay T; Szombathy G; Lakatos L; Kövér B
    Orv Hetil; 1974 Jun; 115(24):1431-3. PubMed ID: 4838513
    [No Abstract]   [Full Text] [Related]  

  • 13. One year longitudinal follow-up of premature infants treated with D-penicillamine in the neonatal period.
    Vekerdy-Lakatos S; Lakatos L; Oroszlán G; Itzés B
    Acta Paediatr Hung; 1987; 28(1):9-16. PubMed ID: 3620199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral D-penicillamine for the prevention of retinopathy of prematurity in very low birth weight infants: a randomized, placebo-controlled trial.
    Tandon M; Dutta S; Dogra MR; Gupta A
    Acta Paediatr; 2010 Sep; 99(9):1324-8. PubMed ID: 20412107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of D-penicillamine on human granulopoiesis in vitro.
    Aymard JP; Herbeuval M; Netter P; Legras B; Streiff F; Herbeuval R
    Scand J Haematol; 1985 Mar; 34(3):219-22. PubMed ID: 3992186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of immune complexes and immunoglobulins induced by D-penicillamine in primary biliary cirrhosis.
    Epstein O; De Villiers D; Jain S; Potter BJ; Thomas HC; Sherlock S
    N Engl J Med; 1979 Feb; 300(6):274-8. PubMed ID: 759879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-penicillamine therapy of neonatal jaundice: comparison with phototherapy.
    Lakatos L; Kövér B; Vekerdy S; Dvorácsek E
    Acta Paediatr Acad Sci Hung; 1976; 17(2):93-102. PubMed ID: 1036444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-Penicillamine for preventing retinopathy of prematurity in preterm infants.
    Phelps DL; Lakatos L; Watts JL
    Cochrane Database Syst Rev; 2000; (2):CD001073. PubMed ID: 10796241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental data on the prevention of retrolental fibroplasia by D-penicillamine.
    Karmazsin L; Lakatos L; Balla G; Makay A; Hatvani L
    Acta Paediatr Acad Sci Hung; 1980; 21(2-3):131-8. PubMed ID: 6894055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heme oxygenase activity is decreased by D-penicillamine in neonates.
    Oroszlán G; Lakatos L; Szabó L; Matkovics B; Karmazsin L
    Experientia; 1983 Aug; 39(8):888-9. PubMed ID: 6688224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.